|
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine |
|
CHEBI:74963 |
|
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine |
|
A phosphatidylcholine 38:6 in which the acyl groups at C-1 and C-2 are specified as hexadecanoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
Lucila Aimo
|
|
CHEBI:73800
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C46H80NO8P/c1-6-8-10-12-14-16-18-20-21-22-23-24-25-27-29-31-33-35-37-39-46(49)55-44(43-54-56(50,51)53-41-40-47(3,4)5)42-52-45(48)38-36-34-32-30-28-26-19-17-15-13-11-9-7-2/h8,10,14,16,20-21,23-24,27,29,33,35,44H,6-7,9,11-13,15,17-19,22,25-26,28,30-32,34,36-43H2,1-5H3/b10-8-,16-14-,21-20-,24-23-,29-27-,35-33-/t44-/m1/s1 |
IESVDEZGAHUQJU-ZLBXKVHBSA-N |
CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC |
|
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via phosphatidylcholine 38:6 )
|
|
View more via ChEBI Ontology
Outgoing
|
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine
(CHEBI:74963)
has functional parent
all-cis-docosa-4,7,10,13,16,19-hexaenoic acid
(CHEBI:28125)
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine
(CHEBI:74963)
has functional parent
hexadecanoic acid
(CHEBI:15756)
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine
(CHEBI:74963)
has role
mouse metabolite
(CHEBI:75771)
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine
(CHEBI:74963)
is a
phosphatidylcholine 38:6
(CHEBI:64519)
|
|
(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyloxy]-3-(palmitoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate
|
1-C16:0-2-C22:6(ω-3)-phosphatidylcholine
|
SUBMITTER
|
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-sn-glycero-3-phosphocholine
|
SUBMITTER
|
1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine
|
UniProt
|
1-palmitoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-sn-glycero-3-phosphocholine
|
ChEBI
|
1-palmitoyl-2-docosahexaenoyl-GPC
|
ChEBI
|
1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)
|
ChEBI
|
1-Palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine
|
LIPID MAPS
|
1-Palmitoyl-2-docosahexaenoylphosphatidylcholine
|
ChemIDplus
|
GPC(16:0/22:6)
|
ChEBI
|
PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
|
LIPID MAPS
|
PC(16:0/22:6)
|
HMDB
|
PC(16:0/22:6)
|
LIPID MAPS
|
PC(16:0/22:6ω3)
|
HMDB
|
PC(38:6)
|
HMDB
|
Phosphatidylcholine(16:0/22:6)
|
HMDB
|
Phosphatidylcholine(16:0/22:6ω3)
|
HMDB
|
Phosphatidylcholine(38:6)
|
HMDB
|
59403-54-2
|
CAS Registry Number
|
ChemIDplus
|
9466294
|
Reaxys Registry Number
|
Reaxys
|
|